Testing effectiveness (Phase 2)Study completedNCT00281541What this trial is testingThe Treatment of Unresectable Stage III or Metastatic Stage IV MelanomaWho this might be right forMelanoma Astellas Pharma Inc 29
Testing effectiveness (Phase 2)Looking for participantsNCT06359860What this trial is testingST-1898 for Unresectable or Metastatic MelanomaWho this might be right forUnresectable or Metastatic Melanoma Beijing Scitech-Mq Pharmaceuticals Limited 64
Large-scale testing (Phase 3)Study completedNCT01721746What this trial is testingCompare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)Who this might be right forUnresectable or Metastatic Melanoma Bristol-Myers Squibb 405
Testing effectiveness (Phase 2)Study completedNCT00110994What this trial is testingTreatment for Subjects With Unresectable Stage III or Stage IV MelanomaWho this might be right forCancerMelanoma Bayer 101
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Not applicableStudy completedNCT03325257What this trial is testingPost-ATU Study of NivolumabWho this might be right forMelanoma Nantes University Hospital 350
Large-scale testing (Phase 3)Study completedNCT00094653What this trial is testingMDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic MelanomaWho this might be right forMelanomaMetastases Bristol-Myers Squibb 1,783
Early research (Phase 1)Ended earlyNCT02419495What this trial is testingPhase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced MalignanciesWho this might be right forAdvanced Malignant Solid NeoplasmClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8+26 more M.D. Anderson Cancer Center 221
Early research (Phase 1)Study completedNCT00003022What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Leptomeningeal CancerWho this might be right forBrain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+4 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)WithdrawnNCT00803374What this trial is testingCombination of Anti-CD137 & Ipilimumab in Patients With MelanomaWho this might be right forMelanoma Bristol-Myers Squibb
Testing effectiveness (Phase 2)WithdrawnNCT01851408What this trial is testingSorafenib and Temsirolimus in Treating Patients With Metastatic, Recurrent, or Unresectable MelanomaWho this might be right forMelanomaRecurrent MelanomaStage III Melanoma+1 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00289640What this trial is testingStudy of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 210
Testing effectiveness (Phase 2)Study completedNCT02009397What this trial is testingA Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma PatientsWho this might be right forMetastatic Melanoma University of Louisville 27
Testing effectiveness (Phase 2)Looking for participantsNCT07155317What this trial is testingTime-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME TrialWho this might be right forAdvanced Acral MelanomaAdvanced Cutaneous MelanomaAdvanced Mucosal Melanoma+7 more Emory University 99
Not applicableLooking for participantsNCT06199713What this trial is testingCorrelating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma PatientsWho this might be right forMelanomaMelanoma Stage IIIMelanoma Stage IV+1 more University of Wisconsin, Madison 24
Early research (Phase 1)Study completedNCT01489059What this trial is testingSafety Study of IL-21/Ipilimumab Combination in the Treatment of MelanomaWho this might be right forMelanoma Bristol-Myers Squibb 42
Early research (Phase 1)Active Not RecruitingNCT02721459What this trial is testingXL888 + Vemurafenib + Cobimetinib for Unresectable BRAF Mutated Stage III/IV MelanomaWho this might be right forMelanomaSkin Cancer H. Lee Moffitt Cancer Center and Research Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT00505635What this trial is testingBiochemotherapy With Temozolomide for Metastatic MelanomaWho this might be right forMelanoma M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)Ended earlyNCT04032704What this trial is testingLadiratuzumab Vedotin in Advanced Solid TumorsWho this might be right forSmall Cell Lung CancerNon-small Cell Lung Cancer, SquamousNon-small Cell Lung Cancer, Non-squamous+6 more Seagen Inc. 205
Testing effectiveness (Phase 2)UnknownNCT01409733What this trial is testingTACE With Drug Eluting Beads Loaded With Doxorubicin in Liver Metastases From Melanoma PatientsWho this might be right forStage IV Melanoma Patients With Unresectable Liver Metastases Heidelberg University 20